- Home
- DASH vs SNY Comparison
DASH vs SNY Comparison
Compare DASH & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DASH | SNY |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8B | 95.7B |
| IPO Year | 2020 | 2001 |
Fundamental Metrics
Financial Performance| Metric | DASH | SNY |
|---|---|---|
| Price | $180.89 | $41.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 45 | 11 |
| Target Price | ★ $257.37 | $53.61 |
| AVG Volume (30 Days) | ★ 3.1M | 3.1M |
| Earning Date | 11-04-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 5.76% |
| EPS Growth | ★ 634.48 | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $13,717,000,000.00 | N/A |
| Revenue This Year | $30.04 | $1.46 |
| Revenue Next Year | $20.76 | $6.51 |
| P/E Ratio | $212.14 | ★ $6.14 |
| Revenue Growth | ★ 27.93 | N/A |
| 52 Week Low | $143.30 | $39.07 |
| 52 Week High | $269.00 | $52.68 |
Technical Indicators
Market Signals| Indicator | DASH | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 53.26 |
| Support Level | $178.51 | $41.19 |
| Resistance Level | $187.91 | $41.88 |
| Average True Range (ATR) | 7.11 | 0.68 |
| MACD | -0.19 | 0.33 |
| Stochastic Oscillator | 9.00 | 81.74 |
Price Performance
Historical ComparisonAbout DASH DoorDash Inc.
DoorDash is an online delivery demand aggregator. Consumers can use its app to order food on demand for delivery or in-store pickup from participating merchants. After acquiring Wolt in 2022, the firm expanded beyond the US to offer this service in Europe and Asia. DoorDash creates a marketplace that lets merchants build an online presence, market their offerings, and meet demand through delivery. The firm provides similar services to non-restaurant businesses, such as grocery, retail, and pet supplies. DoorDash is also rolling out emerging technologies, such as drone delivery, to continually innovate and deliver the best possible service to both supply-side and demand-side participants in its marketplace.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.